Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies and Estimates (Tables)

v3.25.3
Significant Accounting Policies and Estimates (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Disaggregated Revenue by Sales Type

Disaggregated revenue by sales type ($ in thousands):

 

    2025     2024  
    Three Months Ended  
    September 30,  
    2025     2024  
Contract manufacturing   $ 907     $ 864  
Custom and white label finished goods manufacturing     -       -  
Consumer branded products     1,918       1,930  
Medical devices/Other     109       146  
Total   $ 2,934     $ 2,940  

 

    2025     2024  
    Nine Months Ended  
    September 30,  
    2025     2024  
Contract manufacturing   $ 2,718     $ 1,890  
Custom and white label finished goods manufacturing     27       42  
Consumer branded products     5,584       3,515  
Medical devices/Other     296       200  
Total   $ 8,625     $ 5,647  
Schedule of Contract Liabilities From Contract With Customers

The following table provides information about contract liabilities from contracts with our customers ($ in thousands).

 

   

September 30,

2025

   

December 31,

2024

 
Deferred revenue   $ 180     $ 179  
Total Deferred revenue   $ 180     $ 179  
Schedule of Contract Liabilities Balance

Significant changes in the contract liabilities balance during the period are as follows:

 

    Contract liabilities  
Balance, December 31, 2024   $ 179  
Non-cancelable contracts with customers entered during the period     112  
Revenue recognized related to non-cancelable contracts with customers during the period     (111 )
Balance, September 30, 2025   $ 180